💨 Abstract

The article highlights a significant medical breakthrough involving a baby named KJ Muldoon, who was diagnosed with a rare and fatal genetic condition called severe CPS1 deficiency. After being born, KJ was administered an experimental and personalized gene editing therapy using CRISPR technique. Stable for the first 9½ months and showing great signs of recovery, researchers hope this will pave the way for future treatments. Doctors also aim to make such personalized treatments more economically viable.

Courtesy: wtop.com